Thamir M Alshammari1,2, Mohamad Aljofan3, Gehad Subaie4, Talib Hussain4. 1. Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia. 2. Saudi Food and Drug Authority, Riyadh, Saudi Arabia. 3. Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana, Kazakhstan. 4. Department of Pharmacology, College of Pharmacy, University of Hail, Hail, Saudi Arabia.
Abstract
Objectives: Health-care professionals (HCPs) are at very high risk for accidental exposure to hepatitis B virus (HBV) from infected patients; as such, this study aimed to investigate the knowledge, awareness, attitude, and practice of HCPs toward hepatitis B vaccination. Methods: We conducted a cross-sectional study with a pre-tested, validated questionnaire in seven major cities in Saudi Arabia from January to April 2015. The questionnaire consisted of four sections: demographics, knowledge, awareness of hepatitis B infection, and attitude of HCPs toward HBV. We analyzed the data collected from study participants using SAS® V9.2. Results: Approximately 16.5% of participants reported that they had not received the hepatitis B vaccine; however, the majority of participants believed that hepatitis B is common (73.2%) and that vaccination is an effective strategy to reduce disease incidence (75%). Availability of the vaccine was a major barrier to vaccination (48.7%), together with safety concerns surrounding the vaccine (37%).Approximately 31.2% of non-vaccinated participants believed the hepatitis B vaccine is not safe, while only 8% possessed this belief in the vaccinated group. Additionally, 36.4% of non-vaccinated participants were unsure of the effectiveness of the vaccine, compared to 24.3% in the vaccinated group. Inability to afford the vaccine was reported by 18.2% of the non-vaccinated group compared to only 4% of vaccinated participants. Conclusion: There is notable hepatitis B vaccination coverage among HCPs, but observed levels are below global standards. We believe the hurdles preventing non-vaccinated HCPs from being immunized must be addressed.
Objectives: Health-care professionals (HCPs) are at very high risk for accidental exposure to hepatitis B virus (HBV) from infectedpatients; as such, this study aimed to investigate the knowledge, awareness, attitude, and practice of HCPs toward hepatitis B vaccination. Methods: We conducted a cross-sectional study with a pre-tested, validated questionnaire in seven major cities in Saudi Arabia from January to April 2015. The questionnaire consisted of four sections: demographics, knowledge, awareness of hepatitis B infection, and attitude of HCPs toward HBV. We analyzed the data collected from study participants using SAS® V9.2. Results: Approximately 16.5% of participants reported that they had not received the hepatitis B vaccine; however, the majority of participants believed that hepatitis B is common (73.2%) and that vaccination is an effective strategy to reduce disease incidence (75%). Availability of the vaccine was a major barrier to vaccination (48.7%), together with safety concerns surrounding the vaccine (37%).Approximately 31.2% of non-vaccinated participants believed the hepatitis B vaccine is not safe, while only 8% possessed this belief in the vaccinated group. Additionally, 36.4% of non-vaccinated participants were unsure of the effectiveness of the vaccine, compared to 24.3% in the vaccinated group. Inability to afford the vaccine was reported by 18.2% of the non-vaccinated group compared to only 4% of vaccinated participants. Conclusion: There is notable hepatitis B vaccination coverage among HCPs, but observed levels are below global standards. We believe the hurdles preventing non-vaccinated HCPs from being immunized must be addressed.
Entities:
Keywords:
Attitude and knowledge; Hepatitis B vaccine; Saudi Arabia; healthcare professionals
Authors: Iman I Salama; Samia M Sami; Zeinab N Said; Somaia I Salama; Thanaa M Rabah; Ghada A Abdel-Latif; Dalia M Elmosalami; Rehan M Saleh; Aida M Abdel Mohsin; Ammal M Metwally; Amal I Hassanin; Hanaa M Emam; Samia A Hemida; Safaa M Elserougy; Fatma A Shaaban; Walaa A Fouad; Amira Mohsen; Manal H El-Sayed Journal: Vaccine Date: 2018-03-09 Impact factor: 3.641
Authors: Michael G Bruce; Dana Bruden; Debby Hurlburt; Carolyn Zanis; Gail Thompson; Lisa Rea; Michele Toomey; Lisa Townshend-Bulson; Karen Rudolph; Lisa Bulkow; Philip R Spradling; Richard Baum; Thomas Hennessy; Brian J McMahon Journal: J Infect Dis Date: 2016-01-21 Impact factor: 5.226
Authors: Salah T Al Awaidy; Zayid K Al Mayahi; Malak Kaddoura; Ozayr Mahomed; Nathalie Lahoud; Abdinasir Abubakar; Hassan Zaraket Journal: Vaccines (Basel) Date: 2020-11-06